Idiopathic pulmonary fibrosis: state of the art for 2023
AJ Podolanczuk, CC Thomson… - European …, 2023 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …
M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
A global view of pulmonary hypertension
Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …
rapidly growing importance in elderly people, particularly in countries with ageing …
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with an estimated
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …
median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly …
Pulmonary hypertension associated with lung diseases
OA Shlobin, Y Adir, JA Barbera… - European …, 2024 - publications.ersnet.org
Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common
and underrecognised. The presence of PH in the setting of lung disease has been …
and underrecognised. The presence of PH in the setting of lung disease has been …
[HTML][HTML] Physiology of the lung in idiopathic pulmonary fibrosis
The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple
alterations in lung function. These alterations derive from a complex disease process …
alterations in lung function. These alterations derive from a complex disease process …
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide
D Krewski, RA Yokel, E Nieboer… - Journal of Toxicology …, 2007 - Taylor & Francis
Full article: Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium
Hydroxide Skip to Main Content Taylor and Francis Online homepage Taylor and Francis …
Hydroxide Skip to Main Content Taylor and Francis Online homepage Taylor and Francis …
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
Patients with chronic lung diseases, particularly interstitial lung disease and chronic
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …
Validation of proposed criteria for progressive pulmonary fibrosis
Rationale: Criteria for progressive pulmonary fibrosis (PPF) have been proposed, but their
prognostic value beyond categorical decline in FVC remains unclear. Objectives: To …
prognostic value beyond categorical decline in FVC remains unclear. Objectives: To …
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
CS King, SD Nathan - The Lancet Respiratory Medicine, 2017 - thelancet.com
Despite the development of pharmacological therapies that are effective in slowing the
progression of idiopathic pulmonary fibrosis (IPF), it remains a debilitating and lethal …
progression of idiopathic pulmonary fibrosis (IPF), it remains a debilitating and lethal …